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SUMMARY  Spontaneous bacterial peritonitis (SBP) is a serious complication of liver cirrho-
sis and is deﬁ ned as infected ascites in the absence of any recognizable secondary cause of infection. 
Th e aim of the study was to evaluate the prevalence, incidence, pathogens and clinical outcome of 
SBP. Th is prospective observational study included 108 cirrhotic patients with ascites treated during 
18 months. Patients were divided into two groups according to diagnostic criteria of SBP: SBP group 
(n=23) and non-SBP group (n=85). Diﬀ erences in clinical outcomes between the two groups were 
analyzed, including mortality rate, incidence of gastrointestinal bleeding, bacteremia/sepsis and 
frequency of rehospitalization. Th e pathogens responsible for SBP were analyzed in SBP group. Th e 
prevalence of SBP was 21% and incidence 14.1% per year. Statistically signiﬁ cant between-group di-
ﬀ erences were recorded in mortality (26% vs. 4.7%; P=0.017), incidence of gastrointestinal bleeding 
(39% vs. 11.7%; P=0.015) and rehospitalization frequency (47.8% vs. 20%; P=0.05). Th e incidence 
of sepsis following episode of gastrointestinal bleeding was similar in both groups (55.5% vs. 50%; 
P=0.892). Th e following pathogens were responsible for SBP: Escherichia coli (n=7), MRSA (n=2), 
Acinetobacter spp. (n=2), Staphylococcus aureus (n=1), Streptococcus spp. (n=1), Staphylococcus epidermidis 
(n=1) and Enterococcus faecalis (n=1). As indicated by study results, the incidence and mortality of 
SBP were high. Patients with liver cirrhosis and gastrointestinal hemorrhage were found to be at a 
high risk of developing sepsis with or without clinically proven SBP. Th e pathogens responsible for 
SBP were mostly gram-negative microorganisms; however, there were also a signiﬁ cant proportion 
of gram-positive microorganisms and hospital infections with antibiotic-resistant bacteria. Study 
results suggested the spectrum of pathogens to change due to the selection of antibiotic-resistant 
bacteria within the hospital setting.
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Introduction 
Spontaneous bacterial peritonitis (SBP) is a seri-
ous complication in cirrhotic patients with ascites. In 
1971, Conn and Fessel described a syndrome of in-
fected ascitic ﬂ uid in patients with hepatic cirrhosis, 
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which they named SBP1. SBP is by deﬁ nition an in-
fection of previously sterile ascitic ﬂ uid, without any 
apparent intra-abdominal source of infection2. Th e 
pathophysiology of SBP is not completely understood, 
but evidence suggests that bacteria translocate from 
the intestinal lumen to the systemic circulation, caus-
ing bacteremia and subsequent colonization of the as-
citic ﬂ uid3-5. 
Recent studies using newer diagnostic criteria and 
improved culture techniques have estimated the prev-
alence of SBP to 10%-30% of cirrhotic patients with 
ascites admitted to hospitals. Since clinical manifes-
tations of SBP are non-speciﬁ c, the diagnosis of SBP 
is established by the polymorphonuclear cell count in 
ascitic ﬂ uid of 250 cells/mm3 (culture-positive neutro-
cytic ascites)6. Th e organism responsible for the infec-
tion is isolated in 60%-70% of cases if using improved 
culture methods. Th e ascitic ﬂ uid obtained from para-
centesis should be inoculated in blood culture bottle. 
Compared with conventional culture techniques, this 
procedure signiﬁ cantly increases the detection rate of 
responsible microorganism7-9. In patients with SBP, 
studies based on quantitative cultures of ascitic ﬂ uid 
have shown a median bacterial concentration of one 
organism (one bacterium) per milliliter of ascitic ﬂ u-
id7. Th is low concentration explains the low sensitivity 
of conventional culture techniques for the responsible 
microorganism detection. Th e bacteria isolated from 
the ascitic ﬂ uid of patients with SBP are usually those 
of the normal intestinal ﬂ ora. More than 90% of all 
SBP cases are monomicrobial, with aerobic gram-
negative bacilli being responsible for more than two 
thirds of all cases. Escherichia coli accounts for nearly 
half of these cases, followed by Klebsiella species and 
other gram-negative bacteria. Almost 25% of cases are 
caused by gram-positive organisms, with streptococ-
cal species being most common7-9. Today, even with 
intensive treatment, the in-hospital mortality is still 
between 10% and 30%. Early diagnosis and use of a 
more appropriate antibiotic therapy such as third gen-
eration cephalosporins are the most likely reasons for 
improvement in SBP prognosis in recent decades. De-
spite the resolution of the infection, SBP may trigger 
severe complications such as renal impairment, gas-
trointestinal (GI) bleeding and hepatic insuﬃ  ciency, 
which are responsible for the associated mortality (up 
to 70%). Patients recovering from an episode of SBP 
should be considered as potential candidates for liver 
transplantation6.
Th e proﬁ le of SBP may vary with diﬀ erent social 
and etiological factors. Although there are many re-
ports of SBP from both developed and developing 
countries, there have not been many studies conducted 
in Croatia to ﬁ nd out the incidence and mortality of 
SBP. We conducted a prospective cohort study to ﬁ nd 
out the incidence of SBP in cirrhotic patients with as-
cites and tried to associate it with clinical outcome. 
Material and Methods 
Th e study was a hospital based prospective cohort 
study of 18 month duration (January 2006 to June 
2007). Th e study was conducted at a regional hospi-
tal in Karlovac, situated in central Croatia. Karlovac 
General Hospital has a catchment population of 150 
000. Th e aim of the study was to assess the prevalence 
and incidence of SBP and clinical outcome of study 
patients. Th e study included 108 patients with liver 
cirrhosis admitted to Department of Medicine and 
Intensive Care Unit (ICU). Inclusion criteria were 
clinical liver cirrhosis with ascites and upper GI hem-
orrhage in patients with clinical signs of liver cirrhosis 
and ascites. Exclusion criteria were ascites due to re-
nal, cardiac, tubercular or malignant pathology and 
secondary peritonitis. 
Cirrhosis was diagnosed clinically, using labora-
tory tests, sonographic and endoscopic methods. Each 
patient was classiﬁ ed according to Child-Pugh clas-
siﬁ cation4 as a scoring system grading the severity of 
chronic liver disease. Th e Child-Pugh score is calcu-
lated by assigning 1 point for any feature in column 
1, 2 points for any feature in column 2, and 3 points 
for any feature in column 3; class A ≤6; class B 7-9; 
and class C ≥10 (Table 1). Patients were not selected 
according to sociodemographic characteristics, edu-
cation and clinical status. Patients were included ir-
respective of their hepatitis B or C viral status. Th e 
patients with appropriate indication were also sub-
jected to abdominal paracentesis with ascites evacua-
tion. With all aseptic precautions by inserting a 22- or 
18-gauge needle in the left iliac fossa or midline just 
below the umbilicus, abdominal paracentesis was per-
formed and samples referred to the laboratory. Ascitic 
ﬂ uid was collected into ethylene diamine tetracetic 
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acid (EDTA) tube for total leukocyte count and dif-
ferential leukocyte count; into plain vial for biochemi-
cal analysis; and 10 mL of ascitic ﬂ uid were inoculated 
in standard microbiological culture (which was a stan-
dard procedure at our hospital in 2006) or in blood 
culture bottle (BacT/ALERT® FA, Biomerieux Inc., 
Durham, USA; standard procedure at our hospital 
in 2007). We used the usual biochemical, microbio-
logic and cytologic analytical methods to determine 
speciﬁ c weight, total protein, glucose, LDH, and to-
tal leukocyte and neutrophil counts per mm3. Total 
leukocyte count and diﬀ erential leukocyte count were 
determined on a Cell- DYN 3200® (Abbott Diagnos-
tics International).
Cases with ascites were labeled as having SBP and 
were enrolled in the study if the ascitic ﬂ uid analysis 
showed either or both of the following: total polymor-
phonuclear count >250 cells/mm3 and ascitic ﬂ uid cul-
ture positive without surgical cause of infection. SBP 
was diagnosed using standard criteria, i.e. absolute 
neutrophil count >250 cells/mm3 (neutrocytic ascites) 
in the absence of an intra-abdominal source of infec-
tion; and ascitic ﬂ uid cultures positive and neutrophil 
count >250 cells/mm3 (culture-positive neutrocytic 
ascites). If the ascitic ﬂ uid cultures were negative in 
the presence of neutrocytic ascites, these patients were 
characterized as having culture-negative neutrocytic 
ascites (CNNA). Patients with positive ascitic ﬂ uid 
cultures but without neutrocytic ascites were classi-
ﬁ ed as having bacterascites.
Paracentesis was performed as early as possible af-
ter hospitalization, before starting antibiotics. Antibi-
otics (ceftriaxone 2x1 g, 12 hourly, intravenously for 
ﬁ ve to seven days, alternative regimes were ciproﬂ oxa-
cin 2x400 mg or amoxicillin with clavulanic acid 3x1, 
2 g) were started in those patients that had the ascitic 
ﬂ uid polymorphonuclear count of more than 250/
mm3. Antibiotic therapy was modiﬁ ed empirically or 
on the basis of culture sensitivity result (if available). 
Th e patients were clinically treated for decompen-
sated liver cirrhosis. In case of complications, treat-
ment was administered according to literature rec-
ommendations10. All the aforementioned pertinent 
data (clinical parameters, laboratory ﬁ ndings, ultra-
sonography ﬁ ndings, and microbiologic specimens) 
were then fed into a Microsoft Excel spreadsheet and 
statistically processed using the Statistica 7.0 software 
(Statsoft Inc., Tulsa, USA).
Study patients were divided into two groups. 
Group 1 (SPB group) included patients with clini-
Table 1. Child-Pugh classiﬁ cation of cirrhosis
Factor 1 2 3 
Encephalopathy None Stage I-II Stage III-IV 
Ascites None Easily controlled Poorly controlled 
Bilirubin (mg/dL) <2 2-3 >3 
Albumin (g/dL) >3.5 3-3.5 <3 
Prothrombin time (second prolonged) 0-4 4-6 >6 
Table 2. Results according to patient groups
Patient group SBP Non-SBP Total
No. of patients n=23 (21.2%) n=85 (78.8%) N 108
No. of deceased 6 4 10
Total mortality rate per year 26% 4.7% 9.2%
Average Child-Pugh class C (11.7) B (8.2) B
No. of rehospitalized patients per year 11/23 (47.8%) 17/85 (20%) 27/108 (25%)
No. of patients with gastrointestinal bleeding with/
without endoscopic interventions 9/23 (39%) 10/85 (11.7%) 19/108 (17.5%)
Sepsis/bacteremia after endoscopic intervention 5/9 (55.5%) 5/10 (50%) 10/19 (52.6%)
SBP = spontaneous bacterial peritonitis
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cally proven SBP and group 2 (non-SBP group) in-
cluded those without proven SBP. Th e analysis in-
cluded general and clinically pertinent data: sex, age, 
Child-Pugh classiﬁ cation, mortality, rehospitaliza-
tion frequency, SBP, sepsis and GI bleeding. Study 
patients were followed-up through hospital care and 
outpatient services for a year of the ﬁ rst hospitaliza-
tion. Statistical comparisons enabled analysis for the 
possible statistically signiﬁ cant between-group diﬀ er-
ences. Comparisons were done by use of χ2-test and 
the level of signiﬁ cance was set at P<0.05 (2-tail P-
value, diﬀ erence is signiﬁ cant if P<0.05).
Results
Study results are presented in Table 2. Our pro-
spective study included 108 patients (74 male and 34 
female), mean age 57.4±15.1 years, with decompensat-
ed liver cirrhosis with ascites, hospitalized at Depart-
ment of Medicine, Karlovac General Hospital. Study 
patients were divided into two groups: SBP group 
(n=23; 21.2%) and non-SBP group (n=85; 78.8%) 
(Fig. 1). Th e prevalence of SBP during the 18-month 
study period was 21.2%. It is interesting to note that 
the prevalence of SBP among patients included in the 
study in 2007 was as high as 33%. Th e incidence of 
SBP in our cirrhotic patients was 14.1% per year. Th e 
leading etiology of chronic liver disease was alcohol 
related cirrhosis (n=90), followed by virus related cir-
rhosis (n=12), hemochromatosis (n=2), idiopathic hep-
atitis related cirrhosis (n=2), primary biliary cirrhosis 
(n=1), and autoimmune hepatitis (n=1). Eighteen pa-
tients had a past history of ascitic ﬂ uid paracentesis, 
but none of them had documented SBP and/or having 
received SBP prophylaxis. 
Six deaths (mortality rate of 26%) were recorded 
in the SBP group and four deaths (mortality rate of 
Fig. 3. Rehospitalization frequency (SBP = spontaneous bac-
terial peritonitis).
Fig. 4. Incidence of gastrointestinal bleeding in liver cirrhosis 
patients (SBP = spontaneous bacterial peritonitis).
Fig. 1. Prevalence of spontaneous bacterial peritonitis (SBP) 
in hospitalized liver cirrhosis patients.
Fig. 2. Mortality of liver cirrhosis patients (SBP = spontane-
ous bacterial peritonitis).
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34.7%) in the non-SBP group. Th e prevalence of SBP 
was compared by χ2-test, which yielded a statistically 
signiﬁ cant mortality diﬀ erence (P=0.017) (Fig. 2).  
Within a year, rehospitalization was required in 11 
(47.8%) SBP patients and 11 (20%) non-SBP patients 
(χ2-test: SBP group 11/23 vs. non-SBP group 11/85; 
P=0.050) (Fig. 3).
During hospital stay, nine SBP patients (9/23; 
39%) and ten non-SBP patients (10/85; 11.7%) un-
derwent endoscopic intervention (χ2-test: SBP group 
9/23 vs. non-SBP group 10/85; P=0.015) (Fig. 4). 
In the aftermath of GI bleeding with or without 
endoscopic intervention, sepsis with proven bacter-
emia was recorded in ﬁ ve SBP and non-SBP patients 
each (χ2-test, P=0.892) (Fig. 5). Th e following patho-
gens were found to be responsible for SBP: Escheri-
chia coli (n=7), MRSA (n=2), Acinetobacter spp. (n=2), 
Staphylococcus aureus (n=1), Streptococcus spp. (n=1), 
Staphylococcus epidermidis (n=1) and Enterococcus faeca-
lis (n=1) (Table 3).
Discussion
Th e aim of this study was to assess the periodic 
prevalence, incidence, pathogens and clinical outcome 
of SBP in cirrhotic patients treated at our hospital. 
Study results should support the clinical relevance of 
SBP prophylaxis. Th e prevalence of SBP in unselected 
cirrhotic patients with ascites admitted to the hospi-
tal ranges between 10% and 30%2. Our study found a 
21% prevalence of SBP in unselected patients hospi-
talized with the clinical diagnosis of decompensated 
liver cirrhosis. Th e incidence of developing SBP in 
our cirrhotic patients was 14.1% per year. According 
to Navasa et al., the 1-year probability of developing 
ﬁ rst episode of SBP in cirrhotic patients with ascites 
is approximately 10%12. In a series of 127 patients ad-
mitted to the hospital for the treatment of an episode 
of ascites, Llach et al. showed the probability of devel-
oping ﬁ rst episode of SBP to be 11% at 1 year and 15% 
at 3-year follow up12. 
When the patients enrolled in the study in 2007 
were analyzed in separate, the prevalence increased to 
up to 33%, which could be explained by the diagnosis 
and management of SBP at our hospital. Th e present 
study was carried out by diﬀ erent clinicians according 
to a standardized protocol. Paracentesis and ascitic 
ﬂ uid biochemistry were performed in line with a uni-
form protocol, thus reducing variability in handling 
the ascitic ﬂ uid samples. During the study, we im-
proved the microbiologic protocol for ascites. In 2007, 
the ascitic ﬂ uid obtained by paracentesis was inocu-
lated into blood culture bottles. Compared with con-
ventional culture techniques used in 2006, this proce-
dure signiﬁ cantly increased the rate of detection of the 
responsible microorganisms. In our clinical practice, 
this improvement may have reﬂ ected on better results 
recorded in 2007. Th e variation in patient manage-
ment due to the availability of the ascitic ﬂ uid analysis 
results reﬂ ected the practice in the ‘real world’.
Th e organisms cultured were predominantly gram-
negative (60%); however, there also were a signiﬁ cant 
proportion of gram-positive microorganisms (40%) 
and hospital infections with MRSA and Acinetobacter 
baumani (26.6%). Th e spectrum of bacteria cultured 
Fig. 5. Incidence of sepsis/bacteremia following gastrointes-
tinal bleeding episode (SBP = spontaneous bacterial perito-
nitis).
Table 3. Organisms detected in spontaneous bacterial 
peritonitis culture positive cases
Microorganism No. of cases % 
Escherichia coli 7 43.7
MRSA 2 12.5
Acinetobacter species 2 12.5
Streptococcus group A and B 1   6.2 
Staphylococcus aureus 1   6.2 
Staphylococcus epidermidis 1   6.2
Enterococcus faecalis 1   6.2
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in this study diﬀ ered from those reported from some 
previous studies in hospitalized patients with cirrhotic 
ascites. In a study by Fernandez et al., gram-positive 
organisms cultured were explained by norﬂ oxacin 
prophylaxis or previous interventions13. Diﬀ erent 
studies evaluated the emergence of antibiotic-resistant 
bacteria in cirrhotic patients undergoing selective in-
testinal decontamination for the prevention of SBP. 
Th e development of SBP or other infections caused by 
quinolone-resistant organisms, mainly Pseudomonas 
spp. and gram-positive bacteria, in cirrhotic patients 
on quinolone prophylaxis was scarcely reported in ini-
tial controlled trials14-16. More recently, the prevalence 
of such infections has been found to have increased17-
20. A recent study showed clear diﬀ erences in the type 
of bacteria causing infections in cirrhotic patients on 
chronic quinolone prophylaxis: while 67% of infec-
tions in untreated cirrhotic patients were due to gram-
negative organisms, infections in patients receiving 
quinolone prophylaxis were mostly due to gram-
positive organisms (79%). Th is study also showed the 
emergence of severe nosocomial staphylococcal infec-
tions due to methicillin-resistant strains20. 
Although our patients did not receive antimicro-
bial prophylaxis, a high number of hospital acquired 
infections was explained by the use of broad-spectrum 
antibiotics for urinary infections, pneumonia, cutane-
ous abscesses, sepsis, etc. Many of our patients had 
prolonged stay at Intensive Care Unit (ICU) and were 
intubated with vascular and other catheters, which 
could be an independent risk factor for developing 
nosocomial SBP.  
Th e signiﬁ cant proportion of gram-positive mi-
croorganisms and hospital infections recorded in our 
study suggested that the selection of antibiotic-resis-
tant bacteria led to dissemination within the hospital 
setting. Th e results of our study point to the need of 
additional investigation of the risk factors for develop-
ing nosocomial SBP. 
Th e outcome in cirrhotic patients with SBP has 
improved dramatically during the last 20 years. In 
studies published before 1980, the rate of SBP resolu-
tion ranged between 25% and 50% and patient sur-
vival between 0% and 20%. In recent studies, the re-
spective ﬁ gures are 70%-90% and 50%-70%2. In our 
study, the 1-year mortality was 26% in liver cirrhosis 
patients with SBP and 4.7% in patients without SBP 
(P=0.017). According to the literature, the 1- and 
2-year probability of survival after an episode of SBP 
is 30% and 20%, respectively22. 
SBP recurrence is common in patients that have 
recovered from an episode of SBP, estimated to 43% 
at 6 months and 69% at 1 year23. In our study, the fre-
quency of cirrhotic patient rehospitalization within a 
year was signiﬁ cantly higher in SBP group (47.8% vs. 
20.0%; P=0.05) (Fig. 3).  
During hospital stay, cirrhotic patients with SBP 
suﬀ ered from GI bleeding and were subjected to en-
doscopic interventions more frequently than those 
without SBP (39% vs. 11.7%; P=0.015) (Fig. 4). Th ese 
results support the conclusion that bacterial infec-
tions are frequently associated with upper GI bleed-
ing in cirrhotic patients. Recent reports on advances 
in clinical practice suggest that bacterial infections 
are frequently associated with upper GI bleeding in 
cirrhotic patients, which develops in up to 66% (20% 
within the ﬁ rst 48 hours and 35%-66% within two 
weeks)22,24-26. About two thirds of these infections are 
present at hospital admission, whereas the remaining 
third develop during admission as compared with 5% 
to 7% in the general hospital population27. Our results 
suggest a similar conclusion. 
In the aftermath of GI bleeding and endoscopic 
interventions, sepsis with proven bacteremia was re-
corded in ﬁ ve SBP and non-SBP patients each (55.5% 
vs. 50%; P=0.892) (Fig. 5). Th is result supports a con-
clusion that bacteremia and systemic infection are of-
ten complications of GI bleeding in cirrhotic patients. 
Sepsis in cirrhotic patients with proven bacteremia 
was found in both groups in similar proportion. De-
velopment of SBP after an episode of bacteremia was 
in correlation with the stage of liver disease. Th e mean 
Child score was 11.7 (Child C) in SBP group and 8.2 
(Child B) in non-SBP group. It is concluded that the 
development of sepsis and SBP after GI bleeding 
episode are two independent risk factors. Th e strong 
association between infection and variceal bleeding 
in cirrhotic patients has been conﬁ rmed in several 
studies, including association with failure to control 
bleeding, early rebleeding and mortality25.
In conclusion, spontaneous bacterial peritonitis is a 
frequent and severe complication in cirrhotic patients 
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with ascites. Although SBP prognosis has improved 
in recent years, the complications and mortality rate 
associated with this bacterial infection are still high. 
Patients with cirrhosis and SBP have numerous com-
plications and consequently invasive procedures and 
ICU treatment are often needed. Our results showed 
the gram-negative microorganisms to predominate in 
SBP infections; however, there also were a signiﬁ cant 
proportion of gram-positive microorganisms and hos-
pital infections with antibiotic-resistant bacteria. Th e 
signiﬁ cant proportion of gram-positive and hospital 
acquired infections raise concern about the selection 
of antibiotic-resistant bacteria in cirrhotic patients and 
their dissemination within the hospital environment. 
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Sažetak
UČESTALOST I KLINIČKI ISHOD SPONTANOG BAKTERIJSKOG PERITONITISA U BOLNIČKI 
LIJEČENIH BOLESNIKA S JETRENOM CIROZOM: PROSPEKTIVNO OPSERVACIJSKO ISPITIVANJE U 
SREDIŠNJOJ HRVATSKOJ
 
I. Gunjača, I. Francetić 
Spontani bakterijski peritonitis (SBP) je ozbiljna komplikacija izazvana cirozom jetre, a deﬁ nira se kao inﬁ cirani 
ascites u odsutnosti bilo kakvog prepoznatljivog sekundarnog uzroka infekcije. Cilj ove studije bio je utvrditi učestalost, 
incidenciju, patogene i klinički ishod. U ovoj prospektivnoj studiji procijenjeno je 108 bolesnika s jetrenom cirozom i as-
citesom liječenih u razdoblju od 18 mjeseci. Bolesnici su bili podijeljeni u dvije skupine prema dijagnostičkim kriterijima 
za SBP: skupina SBP (n=23) i skupina ne-SBP (n=85). Analizirale su se razlike među dvjema skupinama u kliničkom 
ishodu, odnosno stopa smrtnosti, incidencija gastrointestinalnog krvarenja, bakteremija/sepsa i učestalost ponovnog prij-
ma u bolnicu. U skupini SBP analizirali su se i uzročnici odgovorni za SBP. Učestalost SBP kod naših bolesnika bila je 
21%, a rizik incidencije 14,1% na godinu. Utvrđena je statistički značajna razlika među dvjema skupinama u smrtnosti 
(26% prema 4,7%; P=0,017), incidenciji gastrointestinalnog krvarenja (39% prema 11,7%; P=0,015) i učestalosti ponovnog 
prijma u bolnicu (47,8% prema 20%; P=0,05). Incidencija sepse nakon epizode gastrointestinalnog krvarenja bila je slična 
u dvjema skupinama (55,5% prema 50%; P=0,892). Za SBP su bili odgovorni slijedeći uzročnici: Escherichia coli (n=7), 
MRSA (n=2), Acinetobacter spp. (n=2), Staphylococcus aureus (n=1), Streptococcus spp. (n=1), Staphylococcus epidermidis (n=1) i 
Enterococcus faecalis (n=1). U naših bolesnika bilježi se visoka incidencija i smrtnost od SBP. Bolesnici s jetrenom cirozom 
i gastrointestinalnim krvarenjem imaju visok rizik za razvoj sepse s klinički dokazanim SBP ili bez njega. Među patoge-
nima odgovornim za SBP prevladavaju gram-negativni mikroorganizmi, no zabilježen je i značajan udio gram-pozitivnih 
mikroorganizama i bolničkih infekcija bakterijama otpornim na antibiotike. Rezultati ovoga ispitivanja ukazuju na pro-
mjene u spektru patogena uslijed selekcije bakterija otpornih na antibiotike u bolničkoj sredini.
Ključne riječi: Ciroza jetre – komplikacije; Ciroza jetre – mikrobiologija; Peritonitis – etiologija; Peritonitis – mikrobiologija; 
Bakterijske infekcije – etiologija; Bakterijske infekcije – dijagnostika; Hrvatska
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